For localized information and support, would you like to switch to your country-specific website for {0}?
Dr. Terumichi Nakagawa, PhD
Clinical Chemistry Lead, Clinical Laboratory, Keio University Hospital
Dr. Terumichi Nakagawa leads clinical chemistry operations at Keio University Hospital, a major tertiary medical institution in Tokyo, with a focus on advancing mass spectrometry applications in clinical diagnostics. He holds a Ph.D. in Medicine from Keio University. His research explores the potential of mass spectrometry in clinical laboratory testing through LC-MS/MS-based steroid measurement, DNA methylation analysis, and peptide analysis.
Internationally, he serves as a member of the IFCC HbA1c Network and the IFCC Working Group on Method Evaluation Protocols (WG-MEP). Domestically, he leads mass spectrometry standardization initiatives at the Japanese Society of Biomedical Mass Spectrometry and contributes to the development of national validation guidelines through the Quality Management Committee of the Japan Society of Clinical Chemistry (JSCC). His work centers on the standardization of clinical laboratory testing.